Category 4 'link': Gamp 5
Ensure your configuration supports ALCOA+ principles, specifically around audit trails and electronic signatures.
You must clearly define what the system needs to do. For Category 4, your URS should focus heavily on the . What workflows need to be active? What are the specific user roles? 2. Risk Assessment gamp 5 category 4
Unlike Category 3 software, where audit trails are often standard, a Category 4 system often requires the user to configure how the audit trail functions—what data is captured, how long it is retained, and who has the rights to view or modify it. If these configurations are not defined and validated correctly, the system may fail to meet 21 CFR Part 11 or Annex 11 requirements. Therefore, the validation of Category 4 systems is as much about configuring security and compliance as it is about operational functionality. What workflows need to be active
Category 4 acts as a bridge between these two extremes. It refers to standard software products that are configured by the user or supplier to meet specific business needs. Crucially, these systems do not require the writing of custom source code; instead, they rely on configuration tools provided by the vendor. Common examples include Laboratory Information Management Systems (LIMS), Building Management Systems (BMS), and Supervisory Control and Data Acquisition (SCADA) systems. The user does not change the underlying program logic but configures parameters—such as alarm thresholds, reporting formats, and workflow sequences—to align with their specific GxP processes. Risk Assessment Unlike Category 3 software, where audit
Ensuring the system works for the end-to-end business process in the real world. Why Category 4 is Preferred
The core challenge of Category 4 validation lies in its hybrid nature. Because the software code is standard, the supplier is primarily responsible for the quality of the base product (following GAMP Category 3 principles). However, because the configuration is specific to the user, the pharmaceutical company takes on significant responsibility for ensuring the configured system functions correctly within their specific environment.
In the highly regulated landscape of pharmaceutical, biotechnology, and medical device manufacturing, ensuring patient safety and product quality is paramount. The introduction of computerized systems to automate these processes brought immense efficiency but also introduced new risks. The International Society for Pharmaceutical Engineering (ISPE)’s GAMP 5 (Good Automated Manufacturing Practice) guide provides a risk-based framework for validating these systems. Within this framework, stands as the most prevalent, yet often most misunderstood, category. Unlike inflexible infrastructure or complex custom applications, Category 4 software represents the critical middle ground where business process meets technological flexibility, demanding a nuanced and rigorous validation strategy.